Barbara Fazekas
Overview
Explore the profile of Barbara Fazekas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fazekas B, Hamon S, De Marco Verissimo C, Cwiklinski K, Lopez Corrales J, Gaughan S, et al.
Shock
. 2024 Oct;
63(1):132-140.
PMID: 39455069
Sepsis results from a dysregulated host immune response to infection and is responsible for ~11 million deaths each year. In the laboratory, many aspects of sepsis can be replicated using...
2.
Lawthom C, Didelot A, Coppola A, Aledo-Serrano A, Fazekas B, Sainz-Fuertes R, et al.
Epilepsy Behav
. 2023 Oct;
148:109481.
PMID: 37862873
Objective: To assess the impact of epilepsy and antiseizure medications (ASMs) on sleep quality in people with epilepsy (PWE). Methods: An online survey was conducted in France, Germany, Italy, Spain...
3.
Cormican S, Negi N, Naicker S, Islam M, Fazekas B, Power R, et al.
J Am Soc Nephrol
. 2023 Feb;
34(5):793-808.
PMID: 36799882
Significance Statement: CKD is accompanied by abnormal inflammation, which contributes to progressive loss of functional renal tissue and accelerated cardiovascular disease. Although studies have documented that dysregulation of monocyte maturation...
4.
Fazekas B, Alagesan S, Watson L, Ng O, Conroy C, Catala C, et al.
Stem Cell Rev Rep
. 2022 Jan;
18(4):1444-1460.
PMID: 35013938
Mesenchymal stromal cells (MSCs) ameliorate pre-clinical sepsis and sepsis-associated acute kidney injury (SA-AKI) but clinical trials of single-dose MSCs have not indicated robust efficacy. This study investigated immunomodulatory effects of...
5.
Dorey A, Cwiklinski K, Rooney J, De Marco Verissimo C, Lopez Corrales J, Jewhurst H, et al.
Front Cell Infect Microbiol
. 2021 May;
11:667272.
PMID: 34026663
Trematode parasites of the genus are the cause of liver fluke disease (fasciolosis) in humans and their livestock. Infection of the host involves invasion through the intestinal wall followed by...
6.
Batten I, Robinson M, White A, Walsh C, Fazekas B, Wyse J, et al.
Sci Rep
. 2021 Apr;
11(1):8272.
PMID: 33859290
Type I interferon (IFN) dysregulation is a major contributory factor in the development of several autoimmune diseases, termed type I interferonopathies, and is thought to be the pathogenic link with...
7.
Fazekas B, Megaw B, Eade D, Kronfeld N
Epilepsy Behav
. 2021 Jan;
116:107729.
PMID: 33485165
A qualitative netnographic study of epilepsy conversations posted on public social media sites over a 12-month period was conducted in order to identify key themes and issues for people living...
8.
Fazekas B, Griffin M
Kidney Int
. 2020 Apr;
97(6):1130-1140.
PMID: 32305128
A little over 10 years ago, the therapeutic potential of mesenchymal stromal cells (MSCs) for the treatment of acute kidney injury (AKI) was becoming widely recognized. Since then, there has...
9.
Dooley D, van Timmeren M, OReilly V, Brady G, OBrien E, Fazekas B, et al.
Kidney Int
. 2018 Aug;
94(5):926-936.
PMID: 30158055
Current therapies for treating antineutrophil cytoplasm autoantibody (ANCA)-associated vasculitis include cyclophosphamide and corticosteroids. Unfortunately, these agents are associated with severe adverse effects, despite inducing remission in most patients. Histone deacetylase...